Tag: a

Biology

Vascular Medcure Receives Third FDA Clearance for CAPERE® Thrombectomy System – a Mechanical Device for Treatment of DVT

Newsemia
ANAHEIM, Calif. (PRWEB) December 06, 2019 Southern California medical device manufacturer Vascular Medcure, Inc. has received FDA 510(k) clearance for its latest CAPERE® Thrombectomy System...
Biology

How to Achieve Alignment and Optimal Clinical Trial Supply Forecasting With a Single Source of Truth, Upcoming Webinar Hosted by Xtalks

Newsemia
TORONTO (PRWEB) October 31, 2019 A clinical trial usually involves many different parties, who are not always used to communicating with each other: study managers,...
Biology

Modality Solutions is a Silver Sponsor and Cold Chain Workshop Presenter at the Biomanufacturing World Summit Conference

Newsemia
HOUSTON (PRWEB) October 29, 2019 Modality Solutions, a biopharmaceutical cold chain engineering firm, is pleased to announce its Silver sponsorship and cold chain validation workshop...
Biology

DermBiont Announces Positive Data from Phase 2a Clinical Trial and Start of Phase 2b Clinical Trial for Athlete’s Foot with a Topical Live Biotherapeutic

Newsemia
BOSTON (PRWEB) October 22, 2019 DermBiont, a clinical stage microbiome biotechnology company developing topical live biotherapeutics, has announced that its lead program, DBI-001, met its...
Biology

Tech PR Firm ARPR Honored as a Health Care PR Agency of the Year; Grows HealthIT Practice Group 18% Quarter-Over-Quarter

Newsemia
ATLANTA (PRWEB) October 14, 2019 ARPR , an award-winning tech PR agency at the epicenter of the future of PR, today announced that it has...
Biology

Advantages of Singapore as a Clinical Supply Hub to be Discussed by Catalent at Accelerating Clinical Trials in Asia Conference

Newsemia
SOMERSET, N.J. (PRWEB) September 17, 2019 Catalent, a global leader in clinical supply services, today announced that Julie Delaney, Director, Project and Clinical Supplies Management,...
Latest News

Concept Medical obtient la « désignation de dispositif révolutionnaire » octroyée par la FDA pour le MagicTouch AVF, son ballonnet à élution de sirolimus

Newsemia
TAMPA, Floride–(BUSINESS WIRE)–Concept Medical Inc. (CMI) s’est vu accorder par l’Agence américaine des médicaments (U.S. Food and Drug Administration, FDA) la « désignation de dispositif...
Biology

Roving Blue®, Inc. and Enozo Technologies, Inc. Announce Sales Alliance to Promote a Truly Revolutionary Sanitizing Spray Bottle

Newsemia
LENA, Wis. (PRWEB) August 22, 2019 The EnozoPro® converts ordinary tap water into a sanitizing spray capable of killing 99.9% of some of the most...
Latest News

L’acétate d’abiratérone figure désormais sur la Liste des médicaments essentiels de l’Organisation mondiale de la santé pour le traitement du cancer de la prostate résistant à la castration métastatique

Newsemia
BEERSE, Belgique–(BUSINESS WIRE)–Les sociétés pharmaceutiques Janssen de Johnson & Johnson se réjouissent de la récente décision de l'Organisation mondiale de la santé (OMS) d'inclure l'acétate...
Biology

Leak Detection Associates Announces Expansion to Chinese Market – Partnership Agreement Signed With Shanghai Zillion

Newsemia
EGG HARBOR TOWNSHIP, N.J. (PRWEB) June 12, 2019 Leak Detection Associates (LDA), the world’s premier manufacturer of custom built, helium-based leak testing instruments for the...
Biology

Agrilyst Raises $8 Million Series A Co-Led by Astanor Ventures and Talis Capital; Rebrands to Artemis

Newsemia
NEW YORK (PRWEB) May 22, 2019 Artemis (formerly Agrilyst), the leading enterprise Cultivation Management Platform (CMP), today announced it has closed a $8 million Series...
Latest News

Cutera proposera des traitements esthétiques truSculpt® iD et Laser Genesis® durant le Gift Lounge DPA à Cannes au cours de la 72ème édition du Festival de Cannes

Newsemia
BRISBANE, Calif.–(BUSINESS WIRE)–CUTERA, INC., (Nasdaq: CUTR) (« la Société Cutera, ou la « Société ») un fournisseur leader de systèmes d'esthétique au laser, lumière et autres sources d'énergie...
Latest News

GenSight Biologics annonce la présentation des résultats à 72 semaines de l’étude de Phase III REVERSE avec GS010 au Congrès 2019 de l’American Academy of Neurology (AAN)

Newsemia
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée à la découverte et au développement de thérapies géniques...
Biology

Worcester Polytechnic Institute Helps Develop a Novel Extraction Process that May Provide a More Economical Way to Make a Promising Biofuel

Newsemia
WORCESTER, Mass. (PRWEB) April 18, 2019 Taking a step closer to a “green� replacement for fossil fuels, a research team that includes a chemical engineer...
Biology

Frederick Innovative Technology Center, Inc. – Success Story: Blue Sources & Bluegill, a Win for Tech Transfer

Newsemia
FREDERICK, Md. (PRWEB) April 16, 2019 On April 24th, the Federal Laboratory Consortium (FLC) will honor Blue Sources and their project partner, the U.S. Army...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy